SA Risks Missing R40bn Hemp Industry Opportunity Without Coherent Strategy
South Africa's hemp industry opportunity is significant but at risk without a coherent strategy. Patients relying on local CBD products face supply inconsistencies due to regulatory gaps. Coordinated clinical research and policy alignment are essential…
Veterans Groups Urge Congress to Expand Psychedelic and Cannabis Access
Veterans cannabis psychedelic therapy access is increasingly recognized as vital for treatment-resistant PTSD. Veterans currently face risks seeking therapies outside the VA system. Expanding access would improve clinical supervision and continuity of…
Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead
Brazil cannabis regulatory framework updates mark a shift toward integrating medical cannabis into formal healthcare. New rules for domestic cultivation could expand access to regulated cannabis medicines. This framework emphasizes THC oversight,…
New Cannabis Group Will Help Ground Policy in Science and Patient Experience
A cannabis medicine group policy is working to ground federal discussions in science and patient experience. This approach aims to improve access to cannabinoid therapies. It ensures policies reflect both clinical evidence and real-world patient…
Natural Approaches to Managing Chronic Inflammation with Cannabinoids
The endocannabinoid system chronic inflammation interaction is a promising area for therapeutic exploration. Phytocannabinoids like CBD and THC modulate immune responses relevant to chronic inflammation. Understanding this system can guide safer, more…
Natural Neuroprotection: Exploring Non-Psychoactive Cannabinoids
Non-psychoactive cannabinoids neuroprotection offers promising avenues for neurological health. These compounds interact with the endocannabinoid system to modulate inflammation and oxidative stress. While preclinical data is strong, clinical evidence…
0 days without (Lenny, Simpsons)
When your patient swears they haven’t used cannabis in months, but the urinalysis disagrees with their timeline. Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The Independent Evidence…
Batman Slapping Robin
“Maybe we should try CBD for inflammation.” Batman: “That’s literally what the clinical evidence supports.” Robin gets slapped anyway because evidence-based medicine is apparently still controversial. Further Reading…
Feds Warn About Medical Cannabis & Hemp in Drug Tests
Medical cannabis drug testing risks are a critical concern for patients using hemp and cannabis products. Federal warnings highlight that these substances can cause positive drug screens despite lawful use. Clinicians must counsel patients on these risks…
Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults
A recent study found no link between lifetime cannabis use cognitive decline in older adults. This evidence suggests that past cannabis exposure does not increase dementia risk. Clinicians can use these findings to inform patient discussions about…
